Gepotidacin: A Breakthrough Oral Antibiotic for Treating Drug-Resistant Gonorrhea
A new clinical study suggests that gepotidacin, an oral antibiotic currently used for urinary tract infections, may offer an effective new treatment for gonorrhea, particularly against drug-resistant strains. The phase 3 randomized controlled trial, published in The Lancet and presented at the ESCMID conference, brings hope amid growing concerns about antibiotic resistance in gonorrhea treatment. […]
Gepotidacin: A Breakthrough Oral Antibiotic for Treating Drug-Resistant Gonorrhea Read More »









